N’ọnwa Jenụwarị afọ 2021, e mere emume mwube ntọala maka ntọala ụlọ ọrụ Sinocare iPOCT Industrial Park na saịtị ọrụ ahụ. Ihe oru ngo a bu ogige ulo oru puru iche nke iPOCT nke Sinocare wulitere ya na ntinye ego RMB 1 ijeri. A na-eme atụmatụ ka ekewa ya na modul atọ, ya bụ iCARE mmepụta base, AGEscan mmepụta base na CGM mmepụta base. Mgbe emechara ọrụ ahụ, ọ ga-achọpụta nnukwu mmepụta nke iCARE na iCGMS, ngwaahịa ọhụrụ nke Sinocare mepụtara n'ụwa nile, ma na-enye ihe ngwọta zuru oke maka mgbochi na ọgwụgwọ nke ọrịa na-adịghị ala ala.
Since 2016, Sinocare has launched a global business layout, participated in the acquisition of Trividia Health Inc and PTS in the United States, and actively expanded the POCT testing business such as blood lipids and glycosylated hemoglobin. And through the collaborative innovation of research and development at home and abroad, and the integration of global marketing networks, it has entered the leading camp of global ọbara glucose ọbara ụlọ ọrụ.
A ga-arụ ọrụ ụlọ ọrụ Sinocare iPOCT Industrial Park nke amalitere ọhụrụ n'usoro atọ, yana atụmatụ ihe owuwu ga-abụ afọ ise. Mgbe emechara, a na-eme atụmatụ na ọnụ ahịa mmepụta kwa afọ ga-eru ijeri 3, ụtụ ụtụ ga-abawanye site na nde 200, na ihe fọrọ nke nta ka ọ bụrụ ọrụ 2,000 ga-emepụta. Ka ọ na-enyere aka ịkwalite ike Sinocare zuru oke, ọ na-etinyekwa mkpali n'ime uto nke biomedicine na yinye ụlọ ọrụ ahụike na mpaghara Changsha High-tech.